Fig. 3: LmexCen−/− parasites do not lead to lesion development in immunocompromised mice.
From: Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis

For this experiment, STAT1−/− and STAT4−/− female mice were inoculated in the footpad with 10 × 106 LmexWT or LmexCen−/− promastigotes in the stationary phase. a, b Lesion thickness in footpad of STAT1−/− (a) and STAT4−/− (b) mice. c, e Representative footpad of STAT1−/− (c) and STAT4−/− (e) mice inoculated with LmexWT promastigotes at 16 weeks post infection (wpi). d, f Representative footpad of STAT1−/− (d) and STAT4−/− (f) mice inoculated with LmexCen−/− promastigotes at 24 wpi. g, i Footpad parasitic burden of STAT1−/− (g) and STAT4−/− (i) mice. h, j Lymph node parasitic burden of STAT1−/− (h) and STAT4−/− (j) mice. Data show one representative experiment out of two independent experiments and show mean ± SEM, N = 4 for each group at each time point. Unpaired two-tailed Student’s t-test was performed to compare statistical significance at each time point. A P-value < 0.05 was considered significant. In all panels * represents P ≤ 0.05, ** represents P ≤ 0.01, and *** represents P ≤ 0.001.